Crystalplex
- Company typePrivate
- Founded2004
- HeadquartersPittsburgh, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Crystalplex does
Crystalplex is a privately held for-profit company founded in 2004 and based in Pittsburgh, Pennsylvania. According to its firmographic description, the company provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company operates with a very small team of 1-10 employees, and its stated core capability is the formulation and supply of fluorescent nanoparticles used as reagents or labels in life-science research and clinical diagnostic workflows.
The company's capital history consists of seven small equity rounds between 2007 and 2018, totaling approximately $3.22M, with the only named institutional investor being Pittsburgh Life Sciences Greenhouse (2007 round). No product catalog, pricing model, patents, certifications, customer logos, distribution channels, or partnerships are documented in the available data. The technology block confirms no API, no integrations, no AI capabilities, and no disclosed product launches. Leadership comprises three named individuals: CEO Matt Bootman, founder Tom Petzinger, and CTO Lianhua Qu.
A material operational signal is that the company's primary web domain, crystalplex.com, is currently listed for sale on HugeDomains for $13,595, indicating the digital storefront is no longer active. No funding has been recorded since June 2018. The combination of a multi-year funding drought, absence of disclosed customers or products, and a parked-for-sale domain strongly suggests the company is in a dormant, declining, or wind-down state, although the available data does not definitively confirm a formal cessation of operations.
Crystalplex firmographics
Firmographics- Name
- Crystalplex
- Website
- https://crystalplex.com
- Company type
- Private
- Founded year
- 2004
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Crystalplex industry classification
Industry- Product category
- Biomedical Research Reagents
- NAICS
- Research and Development in Nanotechnology (541713), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)
Keywords
Where Crystalplex is headquartered
LocationHeadquarters
- HQ city
- Pittsburgh
- HQ country
- United States
- HQ region
- North America
Markets served
Crystalplex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Crystalplex product offering
Product offeringCore offering
Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company develops and supplies nanomaterial-based reagents and tools that enable detection, labeling, and imaging applications for life-science researchers and clinical diagnostic developers. Its offerings center on proprietary fluorescent nanoparticle formulations tailored to research and diagnostic use cases.
Product overview
No product or service information available. CrystalPlex.com is currently listed for sale as a domain name on HugeDomains.com for $13,595, with no active company website or product offerings detected in the source data.
Differentiator
Problem solved
Functional benefit
Companies that use Crystalplex
Customer profileIdeal customer profiles1 record
Crystalplex technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Crystalplex partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights3 records
Crystalplex competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: A dominant life-sciences tools and diagnostics incumbent that sells fluorescent reagents, particle-based assays, and imaging consumables, often competing with smaller nanoparticle specialists for the same biomedical research and pathology customers.
- MilliporeSigma (Merck KGaA Life Science): Supplies an extensive catalog of fluorescent nanoparticles, dyes, and reagents for research and diagnostic workflows, representing a broad incumbent competitive reference point.
- Luminex (DiaSorin): A molecular diagnostics and life-sciences research tools company whose bead-based and fluorescent assay platforms overlap with downstream uses of Crystalplex's fluorescent nanoparticle technology.
Direct peers
- Cytodiagnostics: Develops and supplies gold and silver nanoparticles, including fluorescently labeled variants, to biomedical research, diagnostic, and life-sciences customers — closely aligned with Crystalplex's stated markets.
- Ocean NanoTech: Specializes in fluorescent nanoparticles and quantum dots for biomedical research and diagnostic applications — the most direct functional overlap with Crystalplex's nanoparticle platform.
- Nanocs: Manufactures functionalized and fluorescent nanoparticles, proteins, and bioconjugates sold into research and diagnostic applications, matching Crystalplex's product focus.
- Bangs Laboratories: Supplies fluorescent and functionalized microparticles/nanoparticles for diagnostics, life-sciences research, and flow cytometry — directly comparable reagent offering.
- Spherotech: Manufactures fluorescent and magnetic particles for diagnostic and research use, including flow cytometry applications, making it a directly comparable nanoparticle reagent vendor.
Emerging players
- nanoComposix (Fortis Life Sciences): Designs and manufactures precisely engineered nanoparticles, including fluorescent versions, for diagnostics and life-sciences research customers.
- CD Bioparticles: Offers a growing catalog of fluorescent and magnetic nanoparticles for diagnostics and drug delivery — an emerging participant in the same niche as Crystalplex.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks5 records
Key highlights3 records
Customer concentration
Crystalplex social profiles
Digital presenceCrystalplex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Crystalplex leadership team
Management profileNumber of profiles
Profiles3 records
Crystalplex funding detail
Funding detailFunding overview
Funding rounds7 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Crystalplex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Crystalplex
What does Crystalplex do?
Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets. The company develops and supplies nanomaterial-based reagents and tools that enable detection, labeling, and imaging applications for life-science researchers and clinical diagnostic developers. Its offerings center on proprietary fluorescent nanoparticle formulations tailored to research and diagnostic use cases.
When was Crystalplex founded?
Crystalplex was founded in 2004. It employs 1 to 10 people.
Where is Crystalplex based?
Crystalplex is headquartered in Pittsburgh, United States, in the North America region.
Who are Crystalplex's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, MilliporeSigma (Merck KGaA Life Science) and Luminex (DiaSorin). Direct peers are Cytodiagnostics, Ocean NanoTech, Nanocs, Bangs Laboratories and Spherotech. Emerging players are nanoComposix (Fortis Life Sciences) and CD Bioparticles.
Does Crystalplex have an API?
No public API is recorded for Crystalplex.
What industry is Crystalplex in?
Crystalplex's product category is Biomedical Research Reagents. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD). Its NAICS code is 541713 and its SIC code is 2835.